Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Viral Vector Manufacturing
Sort By
Newest First
1 / 2
Viral Vector Manufacturing
Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control
Chris Berger; Kilian Witzel
Avid Bioservices
PAO-02-23-CL-03
Mar 14, 2023
AAV Capsid Engineering
Expanding Patient Access to Gene Therapies through AAV Capsid Engineering
Damien Marsic, Ph.D.
Porton Advanced Solutions
PAO-01-23-CL-02-155
Feb 06, 2023
Viral Vector Manufacturing
Optimizing Transient Transfection for Viral Vector Production
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-022-NI-09
Nov 15, 2022
Viral Vectors
Risk-Based Optimization of Viral Vector Processes Adds Real Value
Elie Hanania, Ph.D.; Tatiana Mello, M.S.
Avid Bioservices
PAO-09-022-CL-05
Oct 25, 2022
Cell and Gene Therapy
State of the Cell and Gene Therapy Market
James Grote
Nice Insight
PAO-10-022-NI-01
Oct 11, 2022
Column: M&A
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
Nigel Walker
Nice Insight
PAO-06-022--NI-12
Jun 24, 2022
Viral Vector Manufacturing
Avid Bioservices, Inc. and CRB Highlight Efforts that Enabled Opening of First Phase of New Viral Vector Facility in California in Only Eight Months
Avid Bioservices
PR-M06-22-05
Jun 16, 2022
Viral Vector Manufacturing
Approaching Viral Vector Manufacturing With an Emphasis on Quality and Design
Chris Berger; Atef Khezri
Avid Bioservices
PAO-05-022-CL-02
May 10, 2022
GMP Certification
GMP Certification for Exothera Further Extends its Viral Vector Manufacturing Capacity
Exothera
PR-M03-22-10
Mar 23, 2022
Viral Vector Manufacturing
Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing
Andrew Moreo; Lenore Giannunzio
Andelyn Biosciences
PAO-02-022-CL-01
Mar 12, 2022
Viral Vectors
Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology
Heidi Trusheim, Ph.D.
IDT Biologika
PAO-02-022-CL-09
Mar 12, 2022
2021 Roundup: The Year of Cell and Gene Therapy
David Alvaro, Ph.D.
Pharma's Almanac
PA734
Dec 20, 2021
Viral Vaccines
Viral Vectors, Vaccines — A New Era Of Collaborative Design
Andreas Neubert, Ph.D.
IDT Biologika
PAO-10-21-CL-17
Nov 08, 2021
Cell and Gene Therapy
Coping with a Talent Shortage and Talent War in Cell and Gene Therapy
Cyrill Kellerhals; Sarah O'Reilly
Andelyn Biosciences
PAO-10-21-CL-12
Oct 26, 2021
Gene Therapy
A Customer-Centric Approach to Cell and Gene Therapy Manufacturing
Drew Brennan
Avid Bioservices
PAO-10-21-CL-06
Oct 13, 2021
Viral Vectors
Navigating Analytical Requirements for GMP Viral Vectors
Will Fountain
Andelyn Biosciences
PAO-10-21-CL-02
Oct 08, 2021
Gene Therapy
Building a Bridge of Equivalence to Facilitate and Implement Rapid Process Changes in Gene Therapy Manufacturing
Wade Macedone; Jonathan Rush; Phillip Vermilion; Samir Acharya, Ph.D.
Andelyn Biosciences
PAO-10-21-CL-01
Oct 07, 2021
Gene Therapy
Pandemic Playbook for Gene Therapy Manufacturing
Ratish Krishnan; David Loong, Ph.D.; Nargisse El-Hajjami, Ph.D.
MilliporeSigma
PAO-09-21-CL-14
Sep 29, 2021
Gene Therapy
Andelyn Biosciences: A New CDMO with Roots in Gene Therapy Research Set to Drive Key Manufacturing Advances
Wade Macedone; Mayo Pujols
Andelyn Biosciences
PA823
Aug 03, 2021
Cell and Gene Therapy
Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies
David Y. H. Chang, Ph.D.
WuXi Advanced Therapies
PAO-05-21-CL-05
May 27, 2021
1 / 2
